Northern Trust’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-758,520
| Closed | -$70.5M | – | 4845 |
|
|
2021
Q4 | $70.5M | Sell |
758,520
-7,770
| -1% | -$512K | 0.01% | 858 |
|
|
2021
Q3 | $45.6M | Sell |
766,290
-2,944
| -0.4% | -$174K | 0.01% | 1151 |
|
|
2021
Q2 | $52.5M | Sell |
769,234
-10,957
| -1% | -$714K | 0.01% | 1101 |
|
|
2021
Q1 | $54.1M | Sell |
780,191
-190,240
| -20% | -$14.6M | 0.01% | 1047 |
|
|
2020
Q4 | $74.6M | Sell |
970,431
-26,077
| -3% | -$1.95M | 0.01% | 799 |
|
|
2020
Q3 | $74.5M | Buy |
996,508
+149,309
| +18% | +$9.95M | 0.02% | 684 |
|
|
2020
Q2 | $53.3M | Buy |
847,199
+189,491
| +29% | +$10.4M | 0.01% | 840 |
|
|
2020
Q1 | $27.6M | Buy |
657,708
+5,531
| +0.8% | +$254K | 0.01% | 1175 |
|
|
2019
Q4 | $29.6M | Buy |
652,177
+21,839
| +3% | +$1.03M | 0.01% | 1417 |
|
|
2019
Q3 | $28.9M | Buy |
630,338
+20,691
| +3% | +$1.16M | 0.01% | 1384 |
|
|
2019
Q2 | $35.7M | Buy |
609,647
+6,915
| +1% | +$357K | 0.01% | 1248 |
|
|
2019
Q1 | $27M | Buy |
602,732
+3,977
| +0.7% | +$182K | 0.01% | 1437 |
|
|
2018
Q4 | $23.3M | Sell |
598,755
-5,128
| -0.8% | -$201K | 0.01% | 1452 |
|
|
2018
Q3 | $27.8M | Buy |
603,883
+11,438
| +2% | +$464K | 0.01% | 1511 |
|
|
2018
Q2 | $25.8M | Buy |
592,445
+48,671
| +9% | +$2.09M | 0.01% | 1568 |
|
|
2018
Q1 | $21.5M | Buy |
543,774
+78,445
| +17% | +$3.05M | 0.01% | 1635 |
|
|
2017
Q4 | $15.8M | Sell |
465,329
-7,366
| -2% | -$210K | ﹤0.01% | 1893 |
|
|
2017
Q3 | $12.1M | Buy |
472,695
+79,005
| +20% | +$1.81M | ﹤0.01% | 2084 |
|
|
2017
Q2 | $6.64M | Buy |
393,690
+95,317
| +32% | +$1.31M | ﹤0.01% | 2440 |
|
|
2017
Q1 | $4.36M | Buy |
298,373
+9,123
| +3% | +$135K | ﹤0.01% | 2635 |
|
|
2016
Q4 | $4.11M | Buy |
289,250
+2,758
| +1% | +$42.7K | ﹤0.01% | 2670 |
|
|
2016
Q3 | $5.01M | Sell |
286,492
-3,404
| -1% | -$56.5K | ﹤0.01% | 2517 |
|
|
2016
Q2 | $4.96M | Buy |
289,896
+2,531
| +0.9% | +$45.2K | ﹤0.01% | 2469 |
|
|
2016
Q1 | $5.66M | Buy |
287,365
+2,310
| +0.8% | +$37K | ﹤0.01% | 2333 |
|
|
2015
Q4 | $5.42M | Buy |
285,055
+9,059
| +3% | +$185K | ﹤0.01% | 2415 |
|
|
2015
Q3 | $5.27M | Buy |
275,996
+9,974
| +4% | +$339K | ﹤0.01% | 2406 |
|
|
2015
Q2 | $12.3M | Sell |
266,022
-3,237
| -1% | -$140K | ﹤0.01% | 1930 |
|
|
2015
Q1 | $11.8M | Buy |
269,259
+23,907
| +10% | +$1.11M | ﹤0.01% | 1970 |
|
|
2014
Q4 | $8.51M | Sell |
245,352
-10,776
| -4% | -$437K | ﹤0.01% | 2145 |
|
|
2014
Q3 | $10.7M | Sell |
256,128
-2,123
| -0.8% | -$94.8K | ﹤0.01% | 1986 |
|
|
2014
Q2 | $15.1M | Sell |
258,251
-31,075
| -11% | -$1.96M | ﹤0.01% | 1746 |
|
|
2014
Q1 | $18.2M | Sell |
289,326
-26,916
| -9% | -$1.79M | 0.01% | 1641 |
|
|
2013
Q4 | $18.5M | Buy |
316,242
+8,648
| +3% | +$452K | 0.01% | 1595 |
|
|
2013
Q3 | $16.2M | Buy |
307,594
+95
| +0% | +$6.38K | 0.01% | 1628 |
|
|
2013
Q2 | $23.7M | Buy |
+307,499
| New | +$25.1M | 0.01% | 1239 |
|
Northern Trust's ARNA Position: Q1 2022 in Review
Northern Trust sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 758,520 shares — an estimated $70.5M sold.
Northern Trust first reported a position in ARNA in Q2 2013 and held it in 35 quarters. The position peaked at $74.6M in Q4 2020. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Northern Trust reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Northern Trust sold 758,520 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $70.5M.
- Northern Trust first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 35 quarters.
- Northern Trust's Arena Pharmaceuticals Inc position peaked at $74.6M in Q4 2020.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Northern Trust's 13F filing for Q1 2022, filed 13 May 2022.